Zydus Lifesciences Q2 Results: Shares fall after profit drops 27%, margins contract

The North America formulations business reported revenue of ₹33,145 million, up 21% year-on-year and 7% quarter-on-quarter. Growth was driven by sustained volume expansion in the…

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.cnbctv18.com)